Colony Bankcorp (CBAN) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
15 Apr, 2026Executive summary
Achieved operating net income of $8.9 million in Q4 2025, with adjusted EPS of $0.48 and operating ROAA of 1.05%.
Net income for Q4 2025 was $7.8 million ($0.42 per diluted share), up from $5.8 million in Q3 2025 and $7.4 million in Q4 2024.
Completed the merger with TC Federal/TC Bancshares in December, significantly expanding assets and deposits and presence in Georgia and Florida.
Fifth consecutive quarter of net interest margin expansion, reaching 3.32%.
Quarterly cash dividend increased to $0.12 per share.
Financial highlights
Net interest income for Q4 2025 was $26.0 million, up from $20.6 million in Q4 2024, driven by improved asset yields, lower funding costs, and the TC Federal acquisition.
Total assets reached $3.74 billion at December 31, 2025, up $582.7 million from September 30, 2025.
Total loans (excluding held for sale) were $2.38 billion, up $344.2 million from the prior quarter; deposits were $3.07 billion, up $483.2 million.
Operating non-interest income was $11.1 million, with mortgage-related revenue up $270,000 and a $108,000 gain from a $10 million mortgage pool sale.
Noninterest expense for Q4 2025 was $25.7 million, up from $21.3 million in Q4 2024, driven by higher salaries, acquisition costs, and a wire fraud loss.
Outlook and guidance
Expect to achieve 1.20% ROA quarterly starting Q2 2026 as merger synergies are realized.
Project modest net interest margin increases each quarter in 2026, with loan growth at the lower end of the 8%-12% target.
Integration of TC Federal customers is planned for completion in Q1 2026.
Operating expense ratio targeted to return to 1.45% by Q2 2026 as cost savings from the merger are captured.
Effective tax rate expected to remain around 21%.
Latest events from Colony Bankcorp
- Q1 2026 saw $9.5M operating net income, margin growth, and record segment results.CBAN
Q1 202623 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and ESG priorities.CBAN
Proxy filing16 Apr 2026 - Q2 net income rose to $5.5M as expense control and fee income offset margin pressure.CBAN
Q2 20242 Feb 2026 - Q3 2024 saw stable earnings, strong loan growth, and optimism for margin recovery.CBAN
Q3 202418 Jan 2026 - Q4 2024 net income, margin, and deposit growth highlight tech-driven efficiency gains.CBAN
Q4 20249 Jan 2026 - Q1 2025 net income rose to $6.6M, with strong growth, margins, and expanded insurance.CBAN
Q1 202527 Dec 2025 - Up to $150M in securities offered, including $40M at-the-market equity, to fund growth and acquisitions.CBAN
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, executive pay, Stock Purchase Plan, and auditor ratification.CBAN
Proxy Filing2 Dec 2025 - Earnings and margins rose, with a major acquisition set to expand scale and boost EPS.CBAN
Q2 202516 Nov 2025